MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+)

ERR11758173 E-MTAB-13187:Sample 10 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157328 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758174 E-MTAB-13187:Sample 11 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157329 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758175 E-MTAB-13187:Sample 12 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157330 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758176 E-MTAB-13187:Sample 16 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157331 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758177 E-MTAB-13187:Sample 17 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157332 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758178 E-MTAB-13187:Sample 18 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157333 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758179 E-MTAB-13187:Sample 22 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157334 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758180 E-MTAB-13187:Sample 23 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157335 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758181 E-MTAB-13187:Sample 24 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157336 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758182 E-MTAB-13187:Sample 4 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157337 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758183 E-MTAB-13187:Sample 5 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157338 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758184 E-MTAB-13187:Sample 6 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157339 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758185 E-MTAB-13187:Sample 1 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157340 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758186 E-MTAB-13187:Sample 13 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157341 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758187 E-MTAB-13187:Sample 14 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157342 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758188 E-MTAB-13187:Sample 15 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157343 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758189 E-MTAB-13187:Sample 19 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157344 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758190 E-MTAB-13187:Sample 2 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157345 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758191 E-MTAB-13187:Sample 20 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157346 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758192 E-MTAB-13187:Sample 21 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157347 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758193 E-MTAB-13187:Sample 3 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157348 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758194 E-MTAB-13187:Sample 7 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157349 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758195 E-MTAB-13187:Sample 8 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157350 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21 ERR11758196 E-MTAB-13187:Sample 9 MinION sequencing; Nanopore RNA-seq of human cell lines treated with or without nicotinamide adenine dinucleotide (NAD+) ERX11157351 ENA-FIRST-PUBLIC 2023-09-21 ENA-LAST-UPDATE 2023-09-21